| Shamila Garg, MD | |
|
301 E Day Rd, Mishawaka, IN 46545-3455 | |
| (574) 204-7260 | |
| (574) 204-7261 |
| Full Name | Shamila Garg |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 301 E Day Rd, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184663742 | NPI | - | NPPES |
| 03236275 | Medicaid | NY | |
| 300006950 | Medicaid | IN | |
| 1024963730001 | Medicaid | PA | |
| 7190594 | Other | AETNA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Osf Little Company Of Mary Medical Center | Evergreen park, IL | Hospital |
| Palos Community Hospital | Palos heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Psoriasis is linked with increased risks of hypertension and cardiovascular disease, but its effect on the course of cardiovascular disease remains unknown.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
A tiny therapeutic delivery system that can control the body's ability to manufacture proteins has been developed by Saudi Arabia's King Abdullah University of Science and Technology (KAUST) researchers.
A new study, presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery® today, assessed the accuracy of indirect estimated radiation doses of 47 patients during endovascular thoracoabdominal aneurysm repair (eTAAA).
› Verified 2 days ago
| Entity Name | Little Company Of Mary Affiliated Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162086 PECOS PAC ID: 5193629202 Enrollment ID: O20040127000775 |
News Archive
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Psoriasis is linked with increased risks of hypertension and cardiovascular disease, but its effect on the course of cardiovascular disease remains unknown.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
A tiny therapeutic delivery system that can control the body's ability to manufacture proteins has been developed by Saudi Arabia's King Abdullah University of Science and Technology (KAUST) researchers.
A new study, presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery® today, assessed the accuracy of indirect estimated radiation doses of 47 patients during endovascular thoracoabdominal aneurysm repair (eTAAA).
› Verified 2 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Psoriasis is linked with increased risks of hypertension and cardiovascular disease, but its effect on the course of cardiovascular disease remains unknown.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
A tiny therapeutic delivery system that can control the body's ability to manufacture proteins has been developed by Saudi Arabia's King Abdullah University of Science and Technology (KAUST) researchers.
A new study, presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery® today, assessed the accuracy of indirect estimated radiation doses of 47 patients during endovascular thoracoabdominal aneurysm repair (eTAAA).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shamila Garg, MD 301 E Day Rd, Mishawaka, IN 46545-3455 Ph: (574) 204-7260 | Shamila Garg, MD 301 E Day Rd, Mishawaka, IN 46545-3455 Ph: (574) 204-7260 |
News Archive
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Psoriasis is linked with increased risks of hypertension and cardiovascular disease, but its effect on the course of cardiovascular disease remains unknown.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
A tiny therapeutic delivery system that can control the body's ability to manufacture proteins has been developed by Saudi Arabia's King Abdullah University of Science and Technology (KAUST) researchers.
A new study, presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery® today, assessed the accuracy of indirect estimated radiation doses of 47 patients during endovascular thoracoabdominal aneurysm repair (eTAAA).
› Verified 2 days ago
Mini Sra, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Rafat H Ansari, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-234-5123 Fax: 574-282-2813 | |
Dr. Elizabeth Marie Lauber, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Margaret Ann Quate-operacz, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3665 Park Pl W, Suite 300, Mishawaka, IN 46545 Phone: 574-607-4724 Fax: 574-607-4725 | |
Dr. Sayuri Cheruvu, M.B.,B.S Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-237-1328 Fax: 574-237-1348 | |
Anandkumar M Koyani, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 S Main St, Suite 109, Mishawaka, IN 46544 Phone: 574-256-0235 Fax: 574-256-0236 | |
Dr. Yufeng Kevin Wu, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 301 E Day Rd, Ste 200, Mishawaka, IN 46545 Phone: 574-204-7252 Fax: 574-968-0468 |